-+ 0.00%
-+ 0.00%
-+ 0.00%

Xspray Pharma extends SEK 74.6 million Fenja loan to August 2028

PUBT·11/06/2026 07:06:32
Listen to the news
Xspray Pharma extends SEK 74.6 million Fenja loan to August 2028
  • Xspray Pharma extended its SEK 74.6 million loan with Fenja Capital II to August 15, 2028.
  • The loan must be reduced to SEK 50 million by January 5, 2027; Fenja waived certain loan provisions.
  • Fenja's existing 1,175,000 warrants will be canceled and replaced free of charge with five-year Warrants 2026:2 carrying a SEK 13.30 exercise price.
  • The replacement warrants represent approximately 2.5% dilution following the rights issue and any over-allotment issue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XSpray Pharma AB (publ) published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.